Introduction {#Sec1}
============

A recent analysis by the National Pork Board indicated that between 2007 and 2012, the number of piglets born alive per litter improved by 0.25 piglets per year, while the number of piglets weaned per litter improved by only 0.16 piglets per year \[[@CR1]\]. This difference translates into an increase in preweaning mortality of 0.3% per year, and is a concern not only from a production standpoint, but also from an animal well-being standpoint. The increase in the number born alive is likely due to a combination of improved management and genetic selection of breeding animals. Although it was not measured in the study, the disparity between the improvement in the number of piglets born alive and the number of piglets weaned is most likely due to the well known depression in piglet birth weight associated with increased litter size \[[@CR2]\]. Reduced birth weights are a primary factor associated with preweaning mortality \[[@CR3]--[@CR5]\], and may explain the observed increase in preweaning mortality. Finally, depression of birth weights with increasing litter size is a manifestation of limitations on conceptus development that are imposed by uterine capacity.

Uterine capacity {#Sec2}
----------------

Uterine capacity has been defined in a variety of ways. The number of piglets that can be supported by the uterus during gestation until farrowing if the number of potential fetuses is not limiting, is a common definition \[[@CR6]\]. This definition includes stillborn piglets, which die during farrowing, but does not include mummified fetuses, which die at some point during gestation. It does not fully describe uterine capacity in totality because it does not include any component reflecting differences in piglet birth weights. Clearly, a pig uterus that can support ten 2 kg fetuses has greater uterine capacity than a pig uterus that can support ten 1 kg fetuses. Finally, in practice, the independence of uterine capacity from the number of potential fetuses is also problematic. The relationship between the maximum litter size that can be maintained by the uterus and the number of potential embryos is almost certain to be curvilinear. Reports suggest that at moderate intrauterine crowding, litter size reaches a peak. Significant further crowding beyond this point reduces the number of viable embryos/fetuses, probably by reducing the number of embryos able to obtain sufficient uterine space for survival due to intrauterine competition for space among embryos \[[@CR7]\].

Studies of intrauterine crowding and uterine capacity have employed a variety of methods. The most straightforward to apply is unilateral hysterectomy-ovariectomy (UHO) \[[@CR8]\]. In this surgical method, one ovary and one uterine horn are removed. Compensatory ovarian hypertrophy results in a normal ovulation rate, with only half the available uterine space. The intrauterine crowding that results is relatively moderate and uniform between pigs compared to that caused by superovulation \[[@CR9]\], and the UHO surgical procedure is simpler and more reproducible than embryo transfer \[[@CR10]\]. The surgery can be done early in life (i.e., before puberty, typically 100 to 160 days of age) and the pig can be allowed to recover, reducing the interference of the surgery with normal pregnancy physiology that occurs when uterine ligation methods are used \[[@CR11]\]. Genetic selection also increases uterine crowding \[[@CR12]\], but takes several generations to accomplish. Litter size in UHO females has been reported to be independent of ovulation rate, and it has been assumed that the litter size obtained is half the uterine capacity \[[@CR8]\] for that animal. The UHO procedure has been used successfully to select pigs for uterine capacity \[[@CR13], [@CR14]\].

Placental efficiency {#Sec3}
--------------------

There have been some approaches to placental efficiency that have not required an understanding of the underlying mechanisms, but their utility has been controversial and limited. One approach, the fetal weight to placental weight ratio, has been suggested as a broad indicator of placental efficiency \[[@CR15], [@CR16]\]. An early report that this ratio could be used to select animals for placental efficiency, with subsequent improvements in litter size \[[@CR17]\], was not confirmed using more rigorous selection methods over several generations \[[@CR18]\]. Also, litter size was improved in a line selected for uterine capacity but selection did not alter the fetal weight to placental weight ratio and selection for ovulation rate did not alter litter size but did alter the fetal weight to placental weight ratio \[[@CR19]\]. Although it makes sense that the size of a fetus supported by a given size of placenta should reflect placental efficiency, use of the ratio as a measure of placental efficiency fails to consider the ability of the fetus and placenta to adjust efficiency as the size of the placenta is reduced. In other words, if compensatory mechanisms exist to adjust placental efficiency as the size of the placenta is reduced, the fetal weight to placental weight ratio does not measure absolute placental efficiency for a given conceptus, as would be required to implement genetic selection. Instead, the fetal weight to placental weight ratio measures placental efficiency for that conceptus given the size of the placenta. If that same conceptus developed a smaller placenta, compensatory mechanisms would raise placental efficiency, which would then be reflected in the fetal weight to placental weight ratio.

Evidence of compensatory mechanisms for placental efficiency can be found by examining relationships between log fetal weight and log placental weight during gestation \[[@CR20], [@CR21]\]. Huxley \[[@CR22]\] proposed that the slope of log-log relationships between individual body parts or between a body part and the entire organism reflects the relative growth between the two (Figure [1](#Fig1){ref-type="fig"}). A slope of 1 indicates proportional growth, greater than 1 indicates that the y variable grows faster than the x variable, less than one indicates that the y variable grows more slowly than the x variable \[[@CR23]\]. Extending this concept to the fetus and placenta, a slope of one indicates a fully proportional relationship, the fetus is proportionally larger if the placenta is larger. As placental size is reduced, fetal size is also reduced, and the ratio of the two is the same (placental efficiency is constant and no compensatory mechanisms are present). A slope less than one indicates fetal growth is not fully proportional to the size of the placenta. As placental size is reduced, fetal size is less affected (placental efficiency increases suggesting compensatory mechanisms are present). The slope of the relationship between log fetal weight and log placental weight increases throughout gestation, but even in late gestation is still less than one \[[@CR21]\]. Growth of the fetus is not very dependent on placental size during early gestation, and becomes more dependent as gestation advances, but is never fully dependent on placental size. These relationships indicate that compensatory mechanisms are present, even in late gestation.Figure 1**Possible allometric relationships between fetal weight and placental weight are illustrated.** According to Huxley \[[@CR22]\], the relationship between fetal weight and placental weight can be described with the equation fetal weight = constant × placental weight^f/p^ where f and p represent growth rates of the fetus and placenta, respectively. Given this relationship, the slope of the linear relationship between log fetal weight and log placental weight is f/p, the relative growth rates of the two components. The graphs represent **(a)** untransformed and **(b)** log transformed hypothetical relationships where growth is fully proportional (i.e., growth rates are equal; solid line), only 70% of changes in placental weight are reflected in changes in fetal weight (a fetal sparing effect where fetal growth is relatively insensitive to differences in placental weight; small dashes), and 130% of changes in placental weight are reflected in changes in fetal weight (fetal growth is highly sensitive to differences in placental weight; large dashes). In pigs, even during late gestation, the slope of the log fetal weight to log placental weight relationship is less than one, indicating fetal sparing \[[@CR21]\].

Factors affecting placental function {#Sec4}
------------------------------------

The pig placenta is classified as diffuse epitheliochorial \[[@CR24]\]. This distinguishes it from other livestock species in that there are no placentomes (making it diffuse), and both the fetal and maternal epithelial cell layers are maintained throughout gestation (making it epitheliochorial). Numerous factors affect the efficiency of placental transport of nutrients. Generally, these factors fall into two broad categories, physical and nutrient specific. Physical factors include maternal and fetal blood flow (both rates and physical arrangement relative to one another), fetal and maternal interactive surface area, and the distance between maternal and fetal capillaries. These factors globally affect the transport of all nutrients. Nutrient specific factors are as varied as the nutrients transported. To fully understand placental transport, it is necessary to fully characterize the contribution of both categories.

The physical structure of the placenta divides into areolae and interareolar areas \[[@CR25]\]. Areolae take up histotroph secreted by uterine glands \[[@CR26], [@CR27]\]. Histotroph represents nutrient specific transport and will be dealt with later. The interareolar areas consist of a maternal endometrial epithelium layer tightly adhered to a fetal epithelium layer (trophoblast), which becomes folded beginning about day 30 to 35 of gestation (Figure [2](#Fig2){ref-type="fig"}). The folds become more elaborate and more extensive as gestation advances \[[@CR20], [@CR28]\]. During mid gestation, the folds are relatively close to one another. During late gestation, fetal placental stroma grows into the region between the folds creating a stromal space between folds, and secondary folds develop into this space. As this is taking place, the bilayer separating maternal and fetal capillaries becomes thinner, to the point that maternal and fetal capillaries actually indent into, but do not penetrate, the epithelial cell layers. The indentation of capillaries reduces the distance between maternal and fetal capillaries to as little as 2 microns \[[@CR28]\].Figure 2**Schematic showing changes in the pig placental epithelial bilayer during gestation.** On day 60 of pregnancy **(a)** the folded bilayer has a regular appearance and is embedded in placental stroma. The stromal covering of the folds is relatively deep. The fetal placental epithelial cells at the tops (fetus side is up in the figures) of the folds are tall columnar in appearance, the sides and bottoms are lined with cubiodal epithelia. By day 105 of gestation **(b)**, the folded bilayer is wider, more complex and has secondary folds, which increases the interacting surface area. The epithelial cells of the bilayer are thinner to reduce the distance solutes must diffuse. The stromal space between the folds is expanded to accommodate the secondary folds. The stroma covering the folds is thinner and can be absent in placenta of small fetuses. Fetal and maternal capillaries (not shown) are immediately adjacent to the epithelial cells within the folded structure and are arranged in a countercurrent fashion.

Blood flow and angiogenesis of the pig uterus and placenta have received a great deal of attention. Increased uterine blood flow in response to increased litter size has been reported, but appears to be limited \[[@CR29], [@CR30]\]. The fetal weight to placental weight ratio has been reported to be correlated with placental blood vessel density in a comparison of Meishan and European breed pigs \[[@CR15]\]. These results are difficult to interpret, primarily because it is not clear whether the blood vessels adjacent to the bilayer were measured preferentially or whether all placental vessels were included. Because the epithelial bilayer is the interactive surface between the dam and fetus and solute diffusion decreases rapidly with increased distance, only the capillaries directly adjacent to the bilayer are relevant to nutrient transport. Finally, placental expression of vascular endothelial growth factor (VEGF), a known angiogenic growth factor, has been reported to increase with advancing gestation and is also correlated with the fetal weight to placental weight ratio \[[@CR31], [@CR32]\]. These results suggest that fetal placental angiogenesis may contribute to placental efficiency.

Leiser and Dantzer \[[@CR33]\] used microcast techniques to visualize maternal and fetal capillaries and concluded that they were arranged in a cross-countercurrent fashion on opposite sides of and directly adjacent to the epithelial bilayer. According to Leiser and Dantzer \[[@CR33]\], maternal blood enters the structure at the top of the folds and exits at the bottom (fetal side of the placenta is "up"), fetal blood enters near the bottom of the folds and exits at the top. Thus, the capillary arrangement exchanges solutes between the dam and fetus within the axis perpendicular to the surface of the placenta. The distance of the interacting surface along this axis (the width of the folds) should affect efficiency of exchange, because a greater width would increase the interaction distance between the two blood supplies and facilitate exchange.

Vallet and Freking \[[@CR20]\] measured this width throughout gestation and compared placenta associated with the largest and smallest fetuses in litters from UHO gilts. Fold width increased during late gestation, and was greater in the placenta of small fetuses compared to large fetuses. In the same experiment, the width of the stromal area between the top of the folds and the allantois was also measured. This region may represent further room for the width of the folds to expand. The width of this stromal region became progressively less with advancing gestation, and was less in the placenta of small fetuses compared to large fetuses. In placenta of some of the smallest fetuses, a stromal region above the folds was absent, suggesting that no further expansion of the folded bilayer was possible.

Given these results, we have hypothesized that expansion of the width of the folds represents a compensatory mechanism for increasing placental efficiency if the size of the placenta is restricted (e.g., during intrauterine crowding). If expansion of the folds exceeds the available placental stromal width, further compensation is not possible and fetal growth and development are impaired. If this impairment is severe enough, the fetus is lost, contributing to late gestation loss that occurs during intrauterine crowding.

If this hypothesis is true, one strategy for improving litter size would be to focus on mechanisms of placental stroma and folded bilayer development. Stromal tissues are made up of fibroblasts embedded in extracellular matrix, large constituents of which are glycosaminoglycans like hyaluronan and heparan sulfate \[[@CR34], [@CR35]\]. Glycosaminoglycans are polymers of sugar \[[@CR36], [@CR37]\], probably originating primarily from glucose transported from dam to fetus. Thus, adequate stromal development, and therefore ultimately placental compensatory development, is likely to be dependent on adequate glucose transport. Logically, this suggests that placental development and fetal development compete for glucose resources. This is consistent with reports in sheep where the placenta consumes 60% of incoming glucose \[[@CR38]\]. This competition is likely to be most severe during late gestation and suggests there may be mechanisms that regulate whether glucose is directed to either fetal or placental development.

One such mechanism might be generation of fructose. Livestock conceptuses are fructogenic \[[@CR39]\], meaning that a substantial portion of incoming glucose is converted to fructose, primarily by the placenta \[[@CR40]\]. Studies indicate that fructose is oxidized to CO~2~ at 20% the rate of glucose, so once glucose is converted to fructose it is relatively less available for oxidation \[[@CR41], [@CR42]\]. Fructose is an intermediate in glucosamine synthesis and glucosamine is needed for glycosaminoglycan production \[[@CR43]\]. Also of interest, conversion of fructose to glucosamine stimulates mTOR and regulates cell proliferation in porcine and human trophoblast cells, tying fructose to placental development \[[@CR44], [@CR45]\]. We recently compared glucose and fructose concentrations in the blood of fetuses from UHO gilts during late gestation. Neither sugar was related to fetal weight despite large differences (weight range 423 to 1473 g). Glucose concentrations were positively correlated with placental weight (*P* \<0.05; weight range 73 to 413 g), but fructose concentrations were not (Vallet, unpublished observations). This suggests that the concentration of fructose is likely to be regulated within the conceptus. Whether fructose is synthesized to sequester it from oxidation and preserve its use for glycosaminoglycan synthesis, or for some other role in metabolism, requires further study.

Factors that control folded bilayer development are largely unknown. Two types of placental trophoblast cells are present within the folded bilayer, tall columnar cells at the tops of the folds and cuboidal cells at the bottom and sides of the folds. The location of the tall columnar cells at the top of the folds suggested that they might play a role in widening of the folded structure by erosion of the surrounding stroma. To begin to address the control of fold development, enzymes that degrade extracellular matrix components of the stroma, which would be needed to alter bilayer structure, were examined in the placenta throughout gestation. The cDNAs corresponding to two forms of hyaluronidase were cloned from placental tissue. Similarly, two molecular weight forms of hyaluronidase were detectable in placental tissue extracts using zymography \[[@CR35]\], but the correspondence between the cDNAs and molecular weight forms of the proteins has not been fully clarified. Both protein forms increased with advancing gestation and were greater in placenta from small fetuses, which is consistent with a role for these enzymes in fold formation. In addition to hyaluronidase, heparanase was also cloned from placental tissues and expression was examined using in situ hybridization \[[@CR46]\]. Heparanase mRNA was localized to trophoblast cells lining the sides and bottom of the folded bilayer, no labeling was observed in trophoblast cells at the tops of the folds. Heparanase plays a role in modifications of the basement membrane during cell movements within tissues \[[@CR47]\]. Thus, contrary to our hypothesis, the heparanase results suggest that modifications of the folded bilayer occur along the sides and bottoms of the folds.

To gain further insight into the role of the two trophoblast cell types in fold development, we performed a transcriptomic analysis of the two cell types that had been collected from average weight fetuses on day 85 of gestation \[[@CR48]\] using laser capture microdissection combined with high-throughput Illumina sequencing of cDNA (gestation length in the pig is 114 days). Expression levels of 7413 genes were observed by the two cell types combined. Increased expression of 434 genes were observed for tall columnar trophoblast cells compared to cuboidal trophoblast cells, while the expression of 1088 genes were greater in cuboidal trophoblast cells compared to tall columnar cells. Ingenuity Pathway Analysis was used to determine biological pathways that would be affected by these changes in transcription. Of relevance to fold development, pathways involved in cell invasion, motility and movement were increased in the cuboidal cells lining the sides and bottom of the folds compared to tall columnar cells at the tops of the folds. Heparanase sequences were observed in this analysis, and preferential transcription of heparanase in cuboidal cells compared to tall columnar cells was confirmed. These results again suggest that fold development, or at least modifications of the morphology of the epithelial bilayer, is controlled by changes in the sides and bottom of the folds.

Nutrient specific mechanisms {#Sec5}
----------------------------

Most nutrients transported from the dam to the fetus have specific mechanisms that facilitate transfer. Oxygen and CO~2~ cross the bilayer by simple diffusion, but hemoglobin \[[@CR49]\] and carbonic anhydrase \[[@CR50]\] facilitate transport, respectively. Glucose and amino acids are polar molecules that do not cross cell membranes easily, and various proteins facilitate their uptake by cells. Very little is known regarding the specifics of lipid transport. One report indicated that transport of fatty acid across the pig placenta is very poor \[[@CR51]\]. Vitamin and mineral transport is facilitated in a variety of ways. For example, iron in the form of uteroferrin is secreted by the uterine glands as a component of histotroph, which is then taken up by placental epithelial cells within the areolae by pinocytosis \[[@CR26]\]. Histotroph is likely to be a vehicle for the transfer of a variety of nutrients in a similar fashion. An example of a nutrient specific mechanism that facilitates vitamin transport are placental folate binding proteins \[[@CR52], [@CR53]\], which likely mediate folate transport to the developing conceptus.

Our transcriptomic analysis of placental trophoblast cells presented an opportunity to survey genes involved in nutrient transport. To gain further information on transport mechanisms, we focused attention on solute carrier (SLC) genes expressed by the two different types of trophoblast cells. Swine genome 9.2, the version of the genome used for matching of transcriptomic sequences, included 239 SLC genes. This only included SLC genes placed in the completed sequence, and does not include all known SLC genes (e.g., notably absent are SLC2 sugar transporter genes SLC2A1, 2, 3, 5, 6, 9 and 11). In addition to this limitation, only genes with average expression between the two cell types of greater than 1.8 fragments per kilobase of exon model mapped per million mapped reads (FPKM) were considered to be present in the cells \[[@CR48]\] (Table [1](#Tab1){ref-type="table"}). Nevertheless, the results provide information on an extensive list of SLC genes expressed by trophoblast cells, and indicate that numerous genes for glucose, amino acid, lipid, vitamin and mineral transport proteins are expressed by placental trophoblast cells.Table 1**Expression (FPKM) of SLC genes by short cuboidal and tall columnar trophoblast epithelial cells (see Figure** [2](#Fig2){ref-type="fig"} **) from pig placenta collected on day 85 of gestation by laser capture microdissection (n = 4 pigs)**GeneSubstrateNameP value SC versus TCShort cuboidalTall columnarSLC1A3Amino Acidsolute carrier family 1 (glial high affinity glutamate transporter), member 30.008342103.518152.46\*SLC1A5Amino Acidsolute carrier family 1 (neutral amino acid transporter), member 50.00557419.86529.593\*SLC2A10Glucosesolute carrier family 2 (facilitated glucose transporter), member 100.3560811.7742.437SLC2A12Glucosesolute carrier family 2 (facilitated glucose transporter), member 120.01960193.214124.979\*SLC2A13Inositolsolute carrier family 2 (facilitated glucose transporter), member 130.01299538.491\*26.879SLC2A4Glucosesolute carrier family 2 (facilitated glucose transporter), member 40.041113.39\*2.185SLC3A1Amino Acidsolute carrier family 3 (cystine, dibasic and neutral amino acid transporters, activator of cystine, dibasic and neutral amino acid transport), member 10.67675529.25528.814SLC4A1APNonesolute carrier family 4 (anion exchanger), member 1, adaptor protein0.5109533.6253.356SLC4A4Bicarbonatesolute carrier family 4, sodium bicarbonate cotransporter, member 40.404783.6572.806SLC4A7Bicarbonatesolute carrier family 4, sodium bicarbonate cotransporter, member 70.06253.7872.531SLC5A6Vitaminssolute carrier family 5 (sodium-dependent vitamin transporter), member 62.08E-0527.352\*7.827SLC6A6Amino Acidsolute carrier family 6 (neurotransmitter transporter, taurine), member 60.7004813.6914.132SLC6A8Creatinesolute carrier family 6 (neurotransmitter transporter, creatine), member 80.09253.972.598SLC7A2Amino Acidsolute carrier family 7 (cationic amino acid transporter, y + system), member 20.352082.1941.559SLC7A4Amino Acid?solute carrier family 7 (orphan transporter), member 40.612879101.01599.302SLC7A7Amino Acidsolute carrier family 7 (amino acid transporter light chain, y + L system), member 70.0483063.179\*2.013SLC7A8Amino Acidsolute carrier family 7 (amino acid transporter light chain, L system), member 80.0927036.234.956SLC7A9Amino Acidsolute carrier family 7 (glycoprotein-associated amino acid transporter light chain, bo,+ system), member 90.0046432.419\*4.289SLC9A1Na+/H+solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 10.4627242.8273.147SLC9A3R1Na+/H+solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 14.51E-0522.04\*10.738SLC9A6Na+/H+solute carrier family 9, subfamily A (NHE6, cation proton antiporter 6), member 60.5772273.0253.173SLC9A8Na+/H+solute carrier family 9, subfamily A (NHE8, cation proton antiporter 8), member 80.1950395.924.937SLC9A9Na+/H+solute carrier family 9, subfamily A (NHE9, cation proton antiporter 9), member 90.1090264.5896.648SLC10A7steroidssolute carrier family 10 (sodium/bile acid cotransporter family), member 70.2260022.5693.55SLC12A6K+/Cl-solute carrier family 12 (potassium/chloride transporters), member 60.7174376.4586.382SLC13A3Dicarboxylatesolute carrier family 13 (sodium-dependent dicarboxylate transporter), member 30.00419319.292\*28.657SLC13A4Sulfatesolute carrier family 13 (sodium/sulfate symporters), member 41.73E-0691.288\*44.882SLC14A1Ureasolute carrier family 14 (urea transporter), member 1 (Kidd blood group)0.5790993.7595.211SLC15A1Di/tripeptidessolute carrier family 15 (oligopeptide transporter), member 10.109012.2511.715SLC15A2Di/tripeptidessolute carrier family 15 (H+/peptide transporter), member 26.49E-0584.452147.72\*SLC16A10Amino Acidsolute carrier family 16, member 10 (aromatic amino acid transporter)0.05701147.96638.846SLC16A12Creatinesolute carrier family 16, member 12 (monocarboxylic acid transporter 12)5.09E-057.95\*2.177SLC16A14?solute carrier family 16, member 14 (monocarboxylic acid transporter 14)0.0023659.309\*5.651SLC16A7Lactatesolute carrier family 16, member 7 (monocarboxylic acid transporter 2)0.013613.627\*1.939SLC16A9Uratesolute carrier family 16, member 9 (monocarboxylic acid transporter 9)0.3488553.4762.655SLC17A5Acid sugarssolute carrier family 17 (anion/sugar transporter), member 50.6274237.0417.408SLC19A2Thiaminesolute carrier family 19 (thiamine transporter), member 20.0097283.455\*2.193SLC20A1Phosphatesolute carrier family 20 (phosphate transporter), member 10.0035788.612\*4.872SLC22A18Organic cationssolute carrier family 22, member 180.120712.8831.365SLC22A23?solute carrier family 22, member 230.3962483.3153.06SLC22A3Polyaminessolute carrier family 22 (extraneuronal monoamine transporter), member 30.0001453.563\*0.81SLC25A1Mitochondrial citrate, malatesolute carrier family 25 (mitochondrial carrier; citrate transporter), member 10.34720920.09117.097SLC25A11Mitochondrial oxoglutarate, malatesolute carrier family 25 (mitochondrial carrier; oxoglutarate carrier), member 110.1087795.3333.636SLC25A12Mitochondrial Amino Acidsolute carrier family 25 (aspartate/glutamate carrier), member 120.1314057.1945.996SLC25A13Mitochondrial Amino Acidsolute carrier family 25 (aspartate/glutamate carrier), member 130.40935617.1315.642SLC25A14Mitochondrial H+ (uncoupling)solute carrier family 25 (mitochondrial carrier, brain), member 140.7061341.9572.11SLC25A17Mitochondrial CoA, FADsolute carrier family 25 (mitochondrial carrier; peroxisomal membrane protein, 34 kDa), member 170.7219557.9318.946SLC25A20Mitochondrial carnitinesolute carrier family 25 (carnitine/acylcarnitine translocase), member 200.53673618.41220.059SLC25A24Mitochondrial ATPsolute carrier family 25 (mitochondrial carrier; phosphate carrier), member 240.34530512.01410.704SLC25A25Mitochondrial ATPsolute carrier family 25 (mitochondrial carrier; phosphate carrier), member 250.2190671.8372.319SLC25A26Mitochondrial adenosyl-methioninesolute carrier family 25 (S-adenosylmethionine carrier), member 260.4588531.8831.809SLC25A27Mitochondrial H+ (uncoupling)solute carrier family 25, member 270.0509343.482\*2.227SLC25A28Mitochondrial ironsolute carrier family 25 (mitochondrial iron transporter), member 280.3988122.2661.939SLC25A3Mitochondrial phosphatesolute carrier family 25 (mitochondrial carrier; phosphate carrier), member 30.465844207.118195.026SLC25A32Mitochondrial folatesolute carrier family 25 (mitochondrial folate carrier), member 320.3426632.3253.289SLC25A33Mitochondrial UTPsolute carrier family 25 (pyrimidine nucleotide carrier), member 330.027153.591\*1.889SLC25A36Mitochondrial UTPsolute carrier family 25 (pyrimidine nucleotide carrier), member 360.47982310.41911.013SLC25A37Mitochondrial ironsolute carrier family 25 (mitochondrial iron transporter), member 370.6848228.4058.581SLC25A43Mitochondrial ?solute carrier family 25, member 430.0044242.4114.746\*SLC25A44Mitochondrial ?solute carrier family 25, member 440.6608814.9465.013SLC25A46Mitochondrial ?solute carrier family 25, member 460.7142323.6224.053SLC25A5Mitochondrial ADP, ATPsolute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 50.22520473.0194.084SLC26A2Sulfate, chloride, hydroxyl ionssolute carrier family 26 (sulfate transporter), member 20.00256618.742\*9.657SLC27A4Long chain fatty acidssolute carrier family 27 (fatty acid transporter), member 40.7188662.5282.328SLC27A6Long chain fatty acidssolute carrier family 27 (fatty acid transporter), member 60.0019385.536\*1.159SLC29A1Nucleosidessolute carrier family 29 (nucleoside transporters), member 10.00240351.871\*28.705SLC29A3Nucleosidessolute carrier family 29 (nucleoside transporters), member 30.02824.818\*3.052SLC30A4Zincsolute carrier family 30 (zinc transporter), member 40.1372712.3081.538SLC30A6Zincsolute carrier family 30 (zinc transporter), member 60.5448576.7846.425SLC30A7Zincsolute carrier family 30 (zinc transporter), member 70.60620410.94611.388SLC30A9Zincsolute carrier family 30 (zinc transporter), member 90.04034312.638\*9.474SLC31A2Coppersolute carrier family 31 (copper transporters), member 20.6929633.7374.636SLC35A1Nucleotide sugarsolute carrier family 35 (CMP-sialic acid transporter), member A10.0019668.876\*3.703SLC35A3Nucleotide sugar?solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter), member A30.00344219.10733.186\*SLC35A4Nucleotide sugar?solute carrier family 35, member A40.7170812.6592.795SLC35A5Nucleotide sugar?solute carrier family 35, member A50.6834715.0155.377SLC35B1Adenosine phospho-sulfatesolute carrier family 35, member B10.34720914.39813.503SLC35B2Adenosine phospho-sulfatesolute carrier family 35, member B20.538652.752.625SLC35B3Adenosine phospho-sulfatesolute carrier family 35, member B30.3536066.3225.239SLC35C1Nucleotide sugarsolute carrier family 35, member C10.0001619.1\*6.88SLC35D1Nucleotide sugarsolute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D10.6883173.2862.87SLC35E1?solute carrier family 35, member E10.0660814.9532.826SLC35E3?solute carrier family 35, member E30.2657522.0491.612SLC35F2?solute carrier family 35, member F20.101583.1882.186SLC35F5?solute carrier family 35, member F50.28952722.19224.888SLC36A1Amino acidsolute carrier family 36 (proton/amino acid symporter), member 10.15734919.84416.848SLC36A4Amino acidsolute carrier family 36 (proton/amino acid symporter), member 40.1591792.8361.761SLC37A1Sugar phosphatesolute carrier family 37 (glycerol-3-phosphate transporter), member 10.0002953.492\*1.626SLC37A4Sugar phosphatesolute carrier family 37 (glucose-6-phosphate transporter), member 40.1964186.0825.027SLC38A1Amino acidsolute carrier family 38, member 10.02337111.839\*9.529SLC38A6Amino acid?solute carrier family 38, member 60.000993.8347.593\*SLC38A7Glutaminesolute carrier family 38, member 70.6575352.2842.435SLC38A9Amino acid?solute carrier family 38, member 90.2037524.9973.792SLC39A11Zincsolute carrier family 39 (metal ion transporter), member 110.51943918.91820.158SLC39A14Zinc, iron, cadmiumsolute carrier family 39 (zinc transporter), member 145.13E-0519.797\*8.718SLC39A7Zincsolute carrier family 39 (zinc transporter), member 70.6442129.94610.299SLC39A8Zinc, cadmiumsolute carrier family 39 (zinc transporter), member 80.2190826.9484.375SLC39A9Zincsolute carrier family 39 (zinc transporter), member 90.02928912.607\*8.939SLC44A1Cholinesolute carrier family 44, member 10.00404529.54745.151\*SLC44A2Cholinesolute carrier family 44, member 20.50280222.68721.741SLC44A3Choline?solute carrier family 44, member 30.0146836.27310.268\*SLC44A4Thiamine pyro-phosphate, cholinesolute carrier family 44, member 40.0026716.012\*2.58SLC46A3Folate?solute carrier family 46, member 30.2084524.4843.561SLC47A1Organic cations (e.g. creatinine)solute carrier family 47, member 10.6456872.1582.886SLC47A2Organic cations (e.g. creatinine)solute carrier family 47, member 20.604173.1792.282SLCO2A1Prostaglandinssolute carrier organic anion transporter family, member 2A10.00060970.11123.911\*SLCO2B1Steroids, prostaglandinssolute carrier organic anion transporter family, member 2B10.0044573.665\*2.195SLCO4C1thyroxinsolute carrier organic anion transporter family, member 4C11.95E-0568.57\*36.456\*Asterisk indicates greater expression in cell type indicated (P\<0.05).

One final caveat regarding these results is that although SLC genes are all involved in solute transport across membranes, not all are involved in nutrient transport across the plasma membrane, which would be required for a role in transport between the dam and fetus. Many are involved in transport between organelles within cells (e.g., SLC25 genes are all mitochondrial transport genes). Some provide substrate influx into the cell, while others provide substrate efflux, and some do both depending on their cellular location (e.g., apical vs. basal) and the conditions in and around the cell. Because two epithelial cell layers separate maternal and fetal blood in the pig, all nutrients must pass four intact cell membranes to reach the fetal blood, so whether they participate in influx or efflux, they would still contribute to nutrient transport to the fetus. Despite these limitations, the results provide suggestions for future experiments that could be directed at understanding the transport of nutrients and the physiology of the pig placenta.

General {#Sec6}
-------

Of the 293 SLC genes in the Swine Genome build 9.2, 108 genes (37% of total) had expression values greater than 1.8 PKM. Of these, the expression of 30 (28% of expressed) were greater in short cuboidal compared to tall columnar cells, and 10 (9% of expressed) were greater in tall columnar cells compared to short cuboidal cells. This compares to 20,461 genes in Swine Genome build 9.2; 7,413 (36% of total) genes expressed by trophoblast cells, and 1,088 genes (15% of expressed) greater in short cuboidal and 434 genes (6% of expressed) greater in tall columnar cells. Thus, transport genes do not appear to be preferentially expressed by trophoblast cells as a group compared to all genes, but preferential expression of SLC genes by short cuboidal cells appears to be greater generally than tall columnar cells, and greater than the frequency of preferential expression of all genes by short cuboidal cells. This may suggest that nutrient transport occurs preferentially through short cubiodal trophoblast cells, which is also consistent with their small size and greater surface area relative to tall columnar cells.

Sugars {#Sec7}
------

Sugars are polar molecules, and their transport is mediated by specific proteins, facilitative glucose transporters (GLUT) and Na-dependent glucose transporters (SGLT), which are involved in passive and active transport of glucose, respectively \[[@CR54]\]. SLC2 and SLC5 genes, respectively, correspond to these two types of transporters \[[@CR55], [@CR56]\]. Sequences matching SLC2A7 were not observed. The two most highly expressed SLC2 genes were SLC2A12 and 13, corresponding to GLUT12 and proton-dependent inositol transporter, respectively. SLC2A4 and 10 (GLUT4 and 10) were also observed. SLC2A12 expression was greater in tall columnar cells compared to cuboidal cells, while the reverse was true for SLC2A13. GLUT12 and GLUT4 are insulin dependent glucose transporters \[[@CR57]\], but levels of insulin are reported to be very low in the pig fetus \[[@CR39]\]. However, insulin like growth factors (IGF) can also regulate GLUT4 transporters \[[@CR58]\] (similar results are not available for GLUT12), suggesting that IGF1 and 2 may provide regulation of glucose transport to the pig conceptus via changes in GLUT4 and GLUT12. Also, the high expression and increased presence of GLUT12 in tall columnar trophoblast cells suggest that these cells may be specialized to provide a regulatory role for placental function through regulation of glucose transport.

The second highest SLC2 gene expressed by placenta, SLC2A13, corresponds to proton-dependent inositol transporter, which is an inositol-H^+^ cotransporter that follows a proton gradient and therefore represents active transport for inositol \[[@CR59], [@CR60]\]. The high expression of this active transporter suggests (1) that inositol has an important role in some aspect of conceptus development or function and (2) that transport of inositol would be encouraged by acidic conditions within the placenta. Consistent with an important role for inositol, concentrations in the fetus are unusually high (4-5 mmol/L, rivaling fructose), and are greater in small fetuses compared to large fetuses \[[@CR61], [@CR62]\]. Phospholipids containing inositol, and inositol phosphates derived from them, are second messengers for a variety of receptor systems \[[@CR63]\]. Inositol containing lipids also participate in cell membrane fusions required for trafficking of cell membrane components \[[@CR64]\]. In addition, many membrane proteins are anchored to the cell membrane through glycophosphatidylinositol linkages \[[@CR65]\]. Although these second messenger systems and other biochemical processes that require inositol are vital, they are unlikely to require transport of large amounts and high concentrations of inositol. Inositol can also be converted to glucuronic acid through the action of myo-inositol oxygenase (MIOX) \[[@CR66]\]. Sequences matching the MIOX gene were found in trophoblast cells, and were greater in the short cuboidal cells similar to the SLC2A13 sequences. Glucuronic acid is a component of hyaluronan, but mammals like the pig apparently lack the enzymes necessary to generate UDP-glucuronate from glucuronic acid \[[@CR67]\], instead UDP-glucuronate is generated using UDP-glucose as a substrate. Free glucuronic acid can be metabolized to CO~2~ in the pentose shunt pathway, so it could be used for energy. Alternatively, glucuronate is also a substrate for the generation of ascorbic acid \[[@CR68]\]. Ascorbic acid is one of the main antioxidants available to tissues to prevent oxidative damage from free radicals. Ascorbic acid is also required to transfer the iron contained in uteroferrin to transferrin \[[@CR69]\]. Whether inositol is used for inositol lipids and second messengers, glucuronic acid, ascorbic acid or energy generation in conceptus development will require further study.

Amino acids {#Sec8}
-----------

A number of SLC genes are known transporters of amino acids including members of the SLC1, SLC3, SLC6, SLC7, SLC16, SLC36 and SLC38 gene families \[[@CR70]--[@CR76]\] (Table [1](#Tab1){ref-type="table"}). Of these, the three most highly expressed were SLC1A3, SLC7A4 and SLC16A10. The SLC1A3 gene codes for a glutamate/aspartate transport protein \[[@CR74]\] (GLAST). In the brain, this protein is responsible for removal of glutamate, a potent neurotransmitter, from the synaptic space of glutamate releasing neurons. Glutamate is taken up by astrocytes and rapidly converted to glutamine, which is then released back to the neurons for reuptake and synthesis of glutamate. Interestingly, our results indicate that glutamine synthetase is highly expressed by both types of trophoblast cells (GLUL, short cuboidal cells 328.9 FPKM, tall columnar cells 388.2 FPKM), suggesting that some portion of glutamate transported into cells is likely to be converted to glutamine. Consistent with this, the glutamine concentration in fetal plasma was greatest of all the amino acids throughout most of gestation, and was much higher than maternal plasma levels \[[@CR77], [@CR78]\]. As previously indicated, glutamine plays a role in glucosamine synthesis along with fructose, providing substrate for hyaluronan and other glycosamine glycans, and glucosamine synthesis is known to be tied to mTOR control of proliferation of day 12 trophoblast cells \[[@CR44], [@CR45]\]. Thus, it seems possible that glutamine and fructose combine to provide overall regulation of placental development, through generation of glycosaminoglycans and control of proliferation of trophoblast cells.

SLC7A4 codes for the CAT-4 protein, which is related to the other members of SLC7 family of cationic amino acid transporter. Proteins encoded by the SLC7A1, 2 and 3 genes are membrane proteins that transport lysine, arginine and ornithine, and correspond to the y+ amino acid transport system. However, the CAT-4 protein apparently has no intrinsic transporter activity \[[@CR76]\], so its function is not clear. Supplemental arginine is known to increase litter size, possibly through its role in NO synthesis \[[@CR79], [@CR80]\]. However, because it is not clear what role the SLC7A4 gene has in cationic amino acid transport or metabolism, its role in arginine metabolism is also unclear.

The SLC16A10 gene encodes the MCT10 protein, an aromatic amino acid transporter \[[@CR71]\]. Three of the four aromatic amino acids are nutritionally essential (histidine, tryptophan, phenylalanine), while the fourth (tyrosine) can be synthesized from phenyalanine. The high expression of this gene may be related to the fact that most of the transported amino acids cannot be synthesized by the fetus. In addition, the MCT10 protein is not Na+ or H+ coupled, so transport relies on the concentration gradient for these amino acids. The concentrations of all four amino acids in maternal and fetal plasma throughout gestation are consistent with passive transport as the mechanism of transport (fetal concentration is lower than maternal) \[[@CR77]\]. If the high expression of the gene is related to the essential nature of the amino acids and the passivity of transport, it suggests that transport of these amino acids might be particularly sensitive to factors that impair SLC16A10 expression or mRNA translation, or factors that result in reduced concentrations of aromatic amino acids in the maternal blood (e.g. shortages in the diet).

Curiously, trophoblast cells highly express the SLC15A2 gene, which is a di/tripeptide transporter \[[@CR81]\]. This suggests an alternative route of amino acid absorption by the placenta, via absorption of di- and tri-peptides, even though low levels of these are likely to be circulating in maternal blood. Alternatively, this transporter could function to allow transport of specific di- and tripeptides, such as carnosine and glutathione, respectively. Both provide antioxidant activity, which may be important in protecting the fetus from free radicals generated during respiration. Whether significant amino acids are transported to the placenta as di- and tri-peptides, or whether the SLC15A2 gene serves another role in conceptus metabolism will require further study.

Lipids {#Sec9}
------

Of the SLC genes found to be expressed by trophoblast cells, only SLC27A4 and SLC27A6 transport lipids in the form of long chain fatty acids \[[@CR82], [@CR83]\]. Neither of these genes is highly expressed by trophoblast cells (Table [1](#Tab1){ref-type="table"}), which is consistent with previous reports indicating very poor transport of fatty acids by pig placenta \[[@CR51]\]. Alternatively, lipids could be transported to the developing conceptus in the form of triglycerides associated with lipoproteins. Although they are not SLC genes, receptors for lipoprotein complexes are expressed by trophoblast cells, with the greatest being LRP6 (SC cells 10.9, TC cells 8.8 FPKM; McNeel et al., unpublished observations) \[[@CR84]\]. Thus, it is likely that lipids reach the conceptus through two mechanisms, transport as free fatty acids, which appears likely to be poor, and as lipids associated with lipoproteins.

Vitamins {#Sec10}
--------

Vitamins are transported by SLC5A6 (biotin, pantothenic acid) \[[@CR85]\], SLC19A2 (thiamine) \[[@CR86]\], SLC25A32 (mitochondrial folate) \[[@CR87]\], SLC44A1, 2 and 3 (choline) and SLC44A4 (thiamine) \[[@CR88]\] and SLC46A3 (folate) \[[@CR86]\]. The two most highly expressed are SLC5A6 and SLC44A1. SLC5A6 is a multivitamin transporter, and the high expression is likely to be related to the essential nature of these vitamins as cofactors in metabolic reactions. High expression of SLC44A1 (and SLC44A2) suggests that high levels of choline are needed for some aspect of fetal development. Choline is a component of choline containing phospholipids (phosphatidylcholine and sphingomyelin), which themselves are components of cell membranes. Also, choline is a component of the neurotransmitter acetylcholine. Finally, choline is a source of methyl groups for methylation reactions \[[@CR89]\]. Methylations are particularly important for placental function, as many imprinted genes that influence placental function are controlled by differential methylation of gene copies originating from either the sire or the dam \[[@CR90]\].

Minerals {#Sec11}
--------

Zinc is transported by SLC30A4, A6, A7, and A9, and SLC39A7, 8, 9, 11, and 14 \[[@CR91]--[@CR93]\]. The combined expression of these genes suggests that zinc is very important to the physiology and biochemistry of the fetus. Zinc participates in a variety of biochemical reactions, including antioxidant activity (superoxide dismutase) and prostaglandin synthesis \[[@CR94]--[@CR96]\]. But the most important to the fetus is likely to be its incorporation into carbonic anhydrase, which plays a role in metabolism of CO~2~\[[@CR50]\]. Carbonic anhydrase catalyzes the formation of carbonate ion from CO~2~, and is a major mechanism enabling the safe transport in serum of CO2 away from tissues after it is produced. Interestingly, a recent study indicated that supplementation of zinc during late pregnancy reduced the incidence of stillbirths in low birth weight piglets, reinforcing the importance of zinc to the developing pig fetus \[[@CR97]\].

Other minerals are also transported by SLC genes \[[@CR87], [@CR98]--[@CR101]\], specifically iron (SLC25A28 and A37, both mitochondrial), copper (SLC31A2), sulfate (SLC13A4, SLC26 A2) and phosphate (SLC20A1, mitochondrial SLC25A3). Transport by these SLC genes likely support heme production for respiratory chain enzymes, copper containing superoxide dismutase and other copper containing proteins, sulfation of proteoglycans and organic compounds and myriad phosphorylation reactions.

Hormones {#Sec12}
--------

Although not nutrients, transport of hormones in and out of trophoblast cells is likely to have important effects on placental function in an autocrine and paracrine manner, and on the fetus in an endocrine manner. SLC genes \[[@CR102], [@CR103]\] participate in transport of prostaglandins (SLCO21A1), steroids (SLC10A7, SLCO2B1) and thyroid hormones (SLCO4C1). Secretion of prostaglandins by the placenta are key regulators of the initiation of farrowing \[[@CR104]\] and probably also participate in the control of blood flow. Placental tissues secrete large amounts of estrogen \[[@CR105], [@CR106]\], which likely plays a role in mammary gland development during pregnancy. The role of thyroid hormones in the placenta is less clear, but the expression level of the SLCO4C1 gene suggests that further work may be warranted to understand how thyroid hormones may regulate placental function or fetal development in pigs.

Summary {#Sec13}
-------

The pig placenta mediates nutrient transport between the dam and the developing pig fetus. Physical characteristics and the expression of nutrient specific mechanisms of the placenta combine to determine the efficiency of transport of the various nutrients required for the development of a healthy piglet at birth. Further work is needed to understand and enhance the development of the folded epithelial bilayer of the pig placenta. Clues to important transport mechanisms for the pig placenta are found in the expression levels of various genes, but further work is needed to confirm the roles of these genes in transport and suggest dietary or management strategies that will improve the transport of specific nutrients to the developing pig fetus. It is still unclear what nutrients currently limit fetal development in the pig.

Conclusions {#Sec14}
===========

We are only beginning to understand the physiological mechanisms that control the morphology and nutrient transport capability of the pig placenta, but it is likely that further understanding will allow not only improvements in litter size, but also reduction of stillbirth and preweaning mortality. Inefficiencies in placental function during gestation are likely to be a primary contributor to perinatal and neonatal piglet losses, as well as the number of fully formed fetuses at farrowing.

Animal care and use {#Sec15}
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